Pricing Log in Create free account

Genelux Corporation (GNLX) vs Minerva Neurosciences, Inc (NERV)

Genelux Corporation and Minerva Neurosciences, Inc are both Biotechnology companies. Genelux Corporation and Minerva Neurosciences, Inc are of similar size ($115.6M and $112.2M). Across the 8 metrics below, Genelux Corporation leads on 4 and Minerva Neurosciences, Inc on 4.

Valuation

Metric GNLX NERV Biotechnology median
P/E n/m n/m 8.50
P/S 9.67 n/m 9.71
P/B 6.75 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.77 n/m 9.21
Earnings yield (35.54%) (1,207.23%) (33.15%)
Free cash flow yield (26.36%) (24.00%) (25.50%)

Profitability

Metric GNLX NERV Biotechnology median
Gross margin (3.42%) 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (177.93%) 322.05% (56.36%)
Return on assets (121.80%) (629.71%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNLX NERV Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 9.47% (18,347.37%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNLX NERV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.39 20.14 4.72
Net debt to EBITDA 0.44 5.46 0.96

Dividend

Metric GNLX NERV Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GNLX NERV Biotechnology median
Market cap 112.21m 115.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack